Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
about
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicineTherapeutic targeting of cancers with loss of PTEN function.Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentInteraction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence.A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.Should Gleason 6 be labeled as cancer?Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate CancerClinically relevant genetic characterization of prostate tumors: how close are we to the goal?Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping.PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion.Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.
P2860
Q26825186-B824267F-1140-4342-AB3F-7B48621710ADQ27852764-6EC019E3-7651-4B0F-91D9-817BB052D71FQ33852664-84131D70-FB2D-4B80-8791-03C0A261D0ECQ35554127-6FDD760E-3F85-480A-AA15-D88555D6E1D6Q36105102-376DD07B-83FD-4F0E-9F9C-A449DDF045BEQ36469889-F94B7973-F8A3-483D-B726-04316ED88B47Q36753720-EF7A47D8-BEE9-4159-BE7C-865188AC1771Q36887707-1C883FB3-3C9D-4F6B-BBD0-2D53F3CBF6B2Q36931932-460C995A-D3F2-4FFD-91CB-4A0884322434Q37221588-A4A2BD77-BF9B-4EA7-A26F-0754F41C38D6Q38356863-F6F0422C-E6AF-44DC-A3D2-AC27799D09BAQ38833458-476A4157-F395-47A8-91B7-F67E334D2EE5Q38967389-E79C96C3-43AF-437D-88BC-2EED84F3B8F9Q38988252-E494480A-E5F6-4A32-B52D-A687DA525AAFQ39401816-3E706C1F-5F00-4CF2-8311-1D0BAD00EF8EQ41907553-5DF801D2-D400-4C2B-825E-7338A07E6458Q42371556-CCDEF7B6-6D04-4176-886D-5C632003BF18Q43089446-77F8AD9F-C512-4676-8DE4-50EB3C1D7DE8Q43104641-C927BBDA-6005-41C7-B93C-874D58C98E7BQ43269413-F84D06A9-A42C-4D30-82E0-E0D273B13EA8Q51395627-1B54A7FF-4F9D-49DA-BEC7-0D23D831C72AQ51549809-8698C7C3-4150-40A8-A18D-A2D2545858B3Q54474207-5A8E8E08-01C5-48B7-8572-A4B98555EB51
P2860
Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Assessing the order of critica ...... subsequent to ERG gene fusion
@en
Assessing the order of critica ...... subsequent to ERG gene fusion
@nl
type
label
Assessing the order of critica ...... subsequent to ERG gene fusion
@en
Assessing the order of critica ...... subsequent to ERG gene fusion
@nl
prefLabel
Assessing the order of critica ...... subsequent to ERG gene fusion
@en
Assessing the order of critica ...... subsequent to ERG gene fusion
@nl
P2093
P2860
P356
P1476
Assessing the order of critica ...... subsequent to ERG gene fusion
@en
P2093
A M De Marzo
M C Haffner
P2860
P2888
P304
P356
10.1038/PCAN.2013.8
P577
2013-04-02T00:00:00Z
P5875
P6179
1051349316